Fig. 1From: STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionIMT infiltrating the myometrium are images 1 and 2. The myxoid areas are infiltrating the muscle of the myometrium. Image 3 is an immunostain for ALK, diffusely positive in the spindle tumor cellsBack to article page